This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2DW Haslam , WP James . Obesity. Lancet 2005; 366: 1197–209.
3AM Chang , JB Halter . Aging and insulin secretion. Am J Physiol Endocrinol Metab 2003; 284: E7–12.
4JE Morley . Diabetes mellitus: a major disease of older persons. J Gerontol Med Sci 2000; 55: M255–56.
5LN Pani , L Korenda , JB Meigs Effect of aging on A1c levels in individuals without diabetes. Diabetes Care 2008; 31: 1991–99.
6UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.
7UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–66.
8UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703–14.
9UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998; 317: 713–21.
10UK Prospective Diabetes Study Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
12P Gaede , H Lund-Andersen , H-H Parving , O Pedersen . Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580–91.
13R Holman , SK Paul , MA Bethel , DR Matthews , HAW Neil . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577–89.
14The ADVANCE Collaboration Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–72.
15The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. The effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545–55.
16W Duckworth , C Abraira , T Moritz Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–39.
17EW Gregg , K Yaffe , JA Cauley Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Int Med 2000; 160: 174–81.
18R Peila , BL Rodriguez , LJ Launer . Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002; 51: 1256–62.
19JA Luchsinger , C Reitz , B Patel Relation of Diabetes to Mild Cognitive Impairment. Arch Neurol 2007; 64: 570–76.
20RO Roberts , YE Geda , DS Knopman , Christianson TJH Association of Duration and Severity of Diabetes Mellitus With Mild Cognitive Impairment. Arch Neurol 2008; 65: 1066–74.
23JA Sonnen , EB Larson , K Brickell Different Patterns of Cerebral Injury in Dementia With or Without Diabetes. Arch Neurol 2009; 66: 315–24.
24MEJ Lean , FG Pajonk . Patients on atypical anti-psychotic drugs: Another high risk group for type 2 diabetes. Diabetes Care 2003; 26: 1597–607.
25T Cukierman-Yaffe , HC Gerstein , JD Williamson Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial. Diabetes Care 2009; 32: 221–26.
26AG Bertoni , JS Krop , GF Anderson Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care 2002; 25: 471–75.
27N Kagansky , S Levy , E Rimon Hypoglycaemia as a predictor of mortality in hospitalised elderly patients. Arch Intern Med 2003; 163: 1825–29.
28RI Shorr , WA Ray , JR Daugherty Incidence and risk factors for serious hypoglycaemia in older persons using insulin or sulphonylureas. Arch Intern Med 1997; 157: 1681–86.
29A Chelliah , MR Burge . Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention. Drugs and Aging 2004; 21: 511–30.
30RA Whitmer , AJ Karter , K Yaffe Hypoglycaemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009; 301: 1565–72.
31KK Ray , SRK Seshasai , S Wijesuriya Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765–72.